Cargando…

Dexmedetomidine improves attention and recall in agitated critically ill patients

Detalles Bibliográficos
Autores principales:	Mirski, MM, Gill, RG, Murakami, PM, Thompson, CT, Lewin, JL
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067029/ http://dx.doi.org/10.1186/cc9775

Ejemplares similares

Validity and reliability of the Johns Hopkins Adapted Cognitive Exam for critically ill patients
por: Mirski, MM, et al.
Publicado: (2011)

The Richmond agitation–sedation scale and bispectral index during dexmedetomidine sedation
por: Turkmen, A, et al.
Publicado: (2005)

Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children
por: Haenecour, A, et al.
Publicado: (2015)

Characteristics of the use of dexmedetomidine in critically ill children: a Brazilian study
por: Lago, PL, et al.
Publicado: (2015)

Pharmacokinetics of long-lasting, high-dose dexmedetomidine infusions in critically ill patients
por: Iirola, T, et al.
Publicado: (2011)

A comparison of the effect on gastric emptying of propofol or dexmedetomidine in critically ill patients
por: Memis, D, et al.
Publicado: (2005)

Comparison of sedation with dexmedetomidine versus lorazepam in septic ICU patients
por: Pandharipande, P, et al.
Publicado: (2008)

Comparison of cerebral hemodynamic variables in hemorrhagic stroke using dexmedetomidine–propofol versus dexmedetomidine–midazolam
por: Perez-Rada, FJ, et al.
Publicado: (2009)

Critically ill patients with Takotsubo cardiomyopathy
por: Oishi, JO, et al.
Publicado: (2007)

Inflammation causes arginine to become an essential amino acid in critically ill children
por: De Betue, CT, et al.
Publicado: (2011)

Effect of critical illness on the pharmacokinetics and dose-response relationship of midazolam
por: Ovakim, D, et al.
Publicado: (2012)

Applicability of four sedation/agitation scales in Portuguese
por: Nassar, AP, et al.
Publicado: (2007)

Agitation and pain during physiotherapy in intensive care
por: Everingham, K, et al.
Publicado: (2010)

PB.16. Breast screening mammograms: recall or not to recall. What is the golden ratio?
por: Sever, AR, et al.
Publicado: (2014)

Dexmedetomidine as a sedative agent for more than 24 hours in acutely ill patients
por: Morsch, RD, et al.
Publicado: (2005)

Lactate and base deficit are predictors of mortality in critically ill patients with cancer
por: Hajjar, LA, et al.
Publicado: (2011)

IL-6 and ITS correlation to stress hyperglycemia in diabetic and non-diabetic critically ILL septic patients
por: Fayed, AM, et al.
Publicado: (2015)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

Risk factors for agitation in critically ill patients
por: de Almeida, Thiago Miranda Lopes, et al.
Publicado: (2016)

Assessment of antibiotic prescriptions in two French intensive care units
por: Parisot, MP, et al.
Publicado: (2010)

Impact of adoption of safety devices in reducing accidents at work with biological material
por: Zogheib, CT, et al.
Publicado: (2011)

Epidemiological study of accidents with biological material involving healthcare workers exposed to hepatitis B, C and HIV
por: Zogheib, CT, et al.
Publicado: (2011)

Active surveillance for KPC-experiencereport
por: Zogheib, CT, et al.
Publicado: (2011)

The Critically Ill Adults scale
por: Schoonderbeek, J, et al.
Publicado: (2005)

Dysmagnesaemia and Critical Illness Outcomes
por: Homer, LE, et al.
Publicado: (2015)

Dexmedetomidine for endovascular neurosurgery
por: Kase, Y, et al.
Publicado: (2008)

Comparison of the RAMSAY score and the Richmond Agitation Sedation Score for the measurement of sedation depth
por: Riessen, R, et al.
Publicado: (2012)

Quality of life among survivors of prolonged critical illness; a mixed methods study
por: Ramsay, P, et al.
Publicado: (2008)

Does discontinuation of the use of hydroxyethyl starches in the critically ill cardiac surgery patient have an impact on caloric intake?
por: Waele, E De, et al.
Publicado: (2015)

Antiepileptic drugs in critically ill patients
por: Farrokh, Salia, et al.
Publicado: (2018)

Fractal analysis: a new biomarker for determining clot characteristics in critically ill patients
por: Davies, GR, et al.
Publicado: (2012)

Aberrant bone metabolism in critical illness
por: Vanhees, I, et al.
Publicado: (2012)

Biomarkers of delirium in critically ill patients
por: Van den Boogaard, M, et al.
Publicado: (2011)

Nasogastric feeding intolerance in the critically ill
por: OConnor, S, et al.
Publicado: (2011)

Endogenous melatonin in critically ill patients
por: Salice, VS, et al.
Publicado: (2013)

Acute exercise response in the critically ill
por: Collings, N, et al.
Publicado: (2013)

Nutritional support in critically ill patients
por: Thanthulage, S, et al.
Publicado: (2007)

Pseudohyperkalemia during the onset of critical illness
por: Tsolakidis, G, et al.
Publicado: (2004)

Urinary and plasma cytokines in the critically ill
por: Adam, Z, et al.
Publicado: (2006)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_0mkur7tk9b0va6uuittd5o58ne